MoneyWorks4Me

Sanjivani Paranteral - Quaterly Results

05 Feb 2024 Evaluate
The Turnover for the quarter ended December 2023 of Rs. 149.63 millions increase by 64.03% from Rs. 91.22 millions.Net profit surges 73.42% to Rs. 16.51  millions  from Rs. 9.52 millions in the quarter ended December 2023.Operating Profit saw a handsome growth to 22.13 millions from 12.32 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 149.63 91.22 64.03 415.47 273.70 51.80 354.92 306.13 15.94
Other Income 2.54 3.10 -18.06 4.64 5.93 -21.75 5.54 2.43 127.98
PBIDT 22.13 12.32 79.63 65.48 48.05 36.27 61.90 59.69 3.70
Interest 0.77 0.54 42.59 1.66 2.00 -17.00 3.59 2.13 68.54
PBDT 21.36 11.78 81.32 63.82 46.05 38.59 58.31 57.56 1.30
Depreciation 2.35 2.26 3.98 6.96 6.60 5.45 8.88 8.77 1.25
PBT 19.01 9.52 99.68 56.86 39.45 44.13 49.43 48.79 1.31
TAX 2.50 0.00 0.00 7.80 4.31 80.97 4.33 0.32 1253.13
Deferred Tax 0.00 0.00 0.00 0.00 -0.69 -100.00 -6.10 0.32 -2006.25
PAT 16.51 9.52 73.42 49.06 35.14 39.61 45.10 48.47 -6.95
Equity 99.98 99.98 0.00 99.98 99.98 0.00 99.98 99.98 0.00
PBIDTM(%) 14.79 13.51 9.51 15.76 17.56 -10.23 17.44 19.50 -10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..